SIEGALL CLAY B bought IMNM
December 30, 2025 · Form 4 insider transaction
SIEGALL CLAY B bought 4,729 shares of Immunome, Inc. at $21.15 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,729
Price
$21.15
Total value
$100.0K
InsiderSIEGALL CLAY B
RoleOfficer, Director
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 30, 2025
Filing dateDecember 30, 2025
Shares owned after665,254
OwnershipDirect
10b5-1 planNo
AmendedNo